Chemical compound
Relcovaptan Other names (2S )-1-[(2R ,3S )-5-chloro-3-(2-chlorophenyl)-1-(3,4-dimethoxyphenyl)sulfonyl-3-hydroxy-2H -indole-2-carbonyl]pyrrolidine-2-carboxamide ATC code
1-({(2R ,3S )-5-chloro-3-(2-chlorophenyl)-1-[(3,4-dimethoxyphenyl)sulfonyl]-3-hydroxy-2,3-dihydro-1H -indol-2-yl}carbonyl)-L -prolinamide
CAS Number 150375-75-0 Y PubChem CID IUPHAR/BPS ChemSpider 54910 N UNII ChEMBL ChEMBL419667 N CompTox Dashboard (EPA ) DTXSID1045746 Formula C 28 H 27 Cl 2 N 3 O 7 S Molar mass 620.50 g·mol−1 3D model (JSmol)
COC1=C(C=C(C=C1)S(=O)(=O)N2[C@H]([C@](C3=C2C=CC(=C3)Cl)(C4=CC=CC=C4Cl)O)C(=O)N5CCC[C@H]5C(=O)N)OC
InChI=1S/C28H27Cl2N3O7S/c1-39-23-12-10-17(15-24(23)40-2)41(37,38)33-21-11-9-16(29)14-19(21)28(36,18-6-3-4-7-20(18)30)25(33)27(35)32-13-5-8-22(32)26(31)34/h3-4,6-7,9-12,14-15,22,25,36H,5,8,13H2,1-2H3,(H2,31,34)/t22-,25-,28+/m0/s1
N Key:CEBYCSRFKCEUSW-NAYZPBBASA-N
N
N Y (what is this?) (verify)
Relcovaptan (SR-49059 ) is a non-peptide vasopressin receptor antagonist, selective for the V1a subtype.[1] It has shown positive initial results for the treatment of Raynaud's disease and dysmenorrhoea, and as a tocolytic,[2] although it is not yet approved for clinical use.
^ Lemmens-Gruber R, Kamyar M (August 2006). "Vasopressin antagonists". Cellular and Molecular Life Sciences . 63 (15): 1766–79. doi:10.1007/s00018-006-6054-2. PMC 11136164 . PMID 16794787. S2CID 30709102.
^ Decaux G, Soupart A, Vassart G (May 2008). "Non-peptide arginine-vasopressin antagonists: the vaptans". Lancet . 371 (9624): 1624–32. doi:10.1016/S0140-6736(08)60695-9. PMID 18468546. S2CID 1245079.
Last Update: 2024-06-03T06:37:38Z
Relcovaptan (SR-49059) is a non-peptide vasopressin receptor antagonist, selective for the V1a subtype. It has shown positive initial results for the...
Word Count : 108
Last Update: 2024-03-24T10:12:49Z
Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 PF-184563 Relcovaptan SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists:...
Word Count : 3871
Last Update: 2024-06-03T05:14:25Z
of 2009. Unselective (mixed V1A/V2) Conivaptan V1A selective (V1RA) Relcovaptan V1B selective (V3RA) Nelivaptan V2 selective (V2RA) Lixivaptan Mozavaptan...
Word Count : 1059
Last Update: 2023-11-07T18:20:30Z
Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 PF-184563 Relcovaptan SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists:...
Word Count : 1518
Last Update: 2024-05-20T07:47:20Z
Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 PF-184563 Relcovaptan SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists:...
Word Count : 1724
Last Update: 2023-07-06T09:37:08Z
Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 PF-184563 Relcovaptan SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists:...
Word Count : 264
Last Update: 2024-06-24T05:30:10Z
Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 PF-184563 Relcovaptan SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists:...
Word Count : 11649
Last Update: 2024-06-20T15:20:25Z
Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 PF-184563 Relcovaptan SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists:...
Word Count : 2641
Last Update: 2024-06-26T16:45:25Z
Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 PF-184563 Relcovaptan SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists:...
Word Count : 763
Last Update: 2024-03-10T03:10:57Z
Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 PF-184563 Relcovaptan SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists:...
Word Count : 974
Last Update: 2024-03-08T08:21:09Z
Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 PF-184563 Relcovaptan SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists:...
Word Count : 584
Last Update: 2023-08-27T06:01:00Z
Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 PF-184563 Relcovaptan SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists:...
Word Count : 1361
Last Update: 2016-05-30T05:20:03Z
Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 PF-184563 Relcovaptan SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists:...
Word Count : 130
Last Update: 2024-02-03T05:27:53Z
Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 PF-184563 Relcovaptan SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists:...
Word Count : 1913
Last Update: 2024-05-15T00:01:04Z
Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 PF-184563 Relcovaptan SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists:...
Word Count : 2321
Last Update: 2024-03-11T20:29:05Z
Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 PF-184563 Relcovaptan SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists:...
Word Count : 1714
Last Update: 2024-05-09T08:21:55Z
Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 PF-184563 Relcovaptan SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists:...
Word Count : 2492
Last Update: 2024-02-11T10:45:52Z
Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 PF-184563 Relcovaptan SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists:...
Word Count : 1043
Last Update: 2023-12-19T16:38:30Z
Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 PF-184563 Relcovaptan SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists:...
Word Count : 1682
Last Update: 2022-03-27T06:08:19Z
Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 PF-184563 Relcovaptan SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists:...
Word Count : 407
Last Update: 2024-06-03T15:54:18Z
Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 PF-184563 Relcovaptan SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists:...
Word Count : 165
Last Update: 2024-06-11T10:00:35Z
Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 PF-184563 Relcovaptan SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists:...
Word Count : 231
Last Update: 2022-12-09T10:03:59Z
Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 PF-184563 Relcovaptan SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists:...
Word Count : 805